Följ
Mohammad Javad Fattahi
Mohammad Javad Fattahi
Assistant professor of medical immunology, Shiraz University of Medical Sciences, Shiraz, Iran
Verifierad e-postadress på sums.ac.ir
Titel
Citeras av
Citeras av
År
Prostaglandins and rheumatoid arthritis
MJ Fattahi, A Mirshafiey
Arthritis 2012, 2012
1292012
CTLA‐4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers
A Hadinia, SV Hossieni, N Erfani, M Saberi‐Firozi, MJ Fattahi, A Ghaderi
Journal of gastroenterology and hepatology 22 (12), 2283-2287, 2007
912007
Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women
B Khadang, MJ Fattahi, A Talei, AS Dehaghani, A Ghaderi
Cancer genetics and cytogenetics 173 (1), 38-42, 2007
752007
CSF levels of cytokines in neuro-Behçet's disease
AB Haghighi, H Ittehadi, AR Nikseresht, J Rahmati, SG Poorjahromi, ...
Clinical neurology and neurosurgery 111 (6), 507-510, 2009
712009
Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug
MJ Fattahi, M Abdollahi, A Agha Mohammadi, N Rastkari, R Khorasani, ...
Immunopharmacology and immunotoxicology 37 (6), 535-540, 2015
672015
Targeting of crosstalk between tumor and tumor microenvironment by β‐D mannuronic acid (M2000) in murine breast cancer model
F Hosseini, H Hassannia, A Mahdian‐Shakib, F Jadidi‐Niaragh, ...
Cancer medicine 6 (3), 640-650, 2017
482017
p53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients
Z Mojtahedi, MR Haghshenas, SV Hosseini, MJ Fattahi, A Ghaderi
Indian journal of cancer 47 (1), 31-34, 2010
392010
Evaluation of the efficacy and safety of β-d-mannuronic acid in patients with ankylosing spondylitis: a 12-week randomized, placebo-controlled, phase I/II clinical trial
MJ Fattahi, AR Jamshidi, M Mahmoudi, M Vojdanian, MS Yekaninejad, ...
International immunopharmacology 54, 112-117, 2018
372018
Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression
Z Mojtahedi, B Khademi, SB Hashemi, SMB Abtahi, MA Ghasemi, ...
Pathology & Oncology Research 17, 7-10, 2011
372011
Interleukin-18 gene promoter and serum level in women with ovarian cancer
A Samsami Dehaghani, K Shahriary, MA Kashef, S Naeimi, MJ Fattahi, ...
Molecular biology reports 36, 2393-2397, 2009
372009
HER2/neu expression in head and neck squamous cell carcinoma patients is not significantly elevated
Y Sardari, S Pardis, AA Tadbir, MJ Ashraf, MJ Fattahi, H Ebrahimi, ...
Asian Pacific Journal of Cancer Prevention 13 (6), 2891-2896, 2012
332012
Positive and negative effects of prostaglandins in A lzheimer's disease
MJ Fattahi, A Mirshafiey
Psychiatry and Clinical Neurosciences 68 (1), 50-60, 2014
312014
Tissue expression, serum and salivary levels of IL-10 in patients with head and neck squamous cell carcinoma
M Hamzavi, AA Tadbir, G Rezvani, MJ Ashraf, MJ Fattahi, B Khademi, ...
Asian Pacific Journal of Cancer Prevention 14 (3), 1681-1685, 2013
302013
Analysis of BRCA1 and BRCA2 mutations in southern Iranian breast cancer patients
MJ FATAHI, Z Mojtahedi, AN KARIM, ABDA TALEEI, SJ Banani, ...
ARCHIVES OF IRANIAN MEDICINE 12 (6), 584-587, 2009
302009
Serum level of vascular endothelial growth factor in patients with different clinical subtypes of oral lichen planus
M Mardani, J Ghabanchi, MJ Fattahi, AA Tadbir
Iranian Journal of Medical Sciences 37 (4), 233, 2012
292012
The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB signaling pathway in ankylosing spondylitis patients
M Roozbehkia, M Mahmoudi, S Aletaha, N Rezaei, MJ Fattahi, ...
International immunopharmacology 52, 191-196, 2017
282017
Seroprevalence of human herpes simplex, hepatitis B and epstein-barr viruses in children with acute lymphoblastic leukemia in southern iran
SB Mahjour, F Ghaffarpasand, MJ Fattahi, A Ghaderi, A Fotouhi Ghiam, ...
Pathology & Oncology Research 16, 579-582, 2010
282010
Preclinical and pharmacotoxicology evaluation of α-l-guluronic acid (G2013) as a non-steroidal anti-inflammatory drug with immunomodulatory property
S Nazeri, S Khadem Azarian, MJ Fattahi, R Sedaghat, F Tofighi Zavareh, ...
Immunopharmacology and Immunotoxicology 39 (2), 59-65, 2017
262017
Oral administration effects of β-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis
MJ Fattahi, H Ahmadi, F Jafarnezhad-Ansariha, SS Mortazavi-Jahromi, ...
Biomedicine & Pharmacotherapy 100, 495-500, 2018
232018
A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of β-d-mannuronic acid in rheumatoid arthritis patients
H Ahmadi, AR Jamshidi, F Gharibdoost, M Mahmoudi, N Rastkari, ...
Inflammopharmacology 26, 737-745, 2018
202018
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20